776
Views
22
CrossRef citations to date
0
Altmetric
Original

STUDY ON A NOVEL STRATEGY TO TREATMENT OF PHENYLKETONURIA

, , , , &
Pages 243-257 | Published online: 11 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Jian Dong Cui, Ji Qing Qiu, Xian Wei Fan, Shi Ru Jia & Zhi Lei Tan. (2014) Biotechnological production and applications of microbial phenylalanine ammonia lyase: a recent review. Critical Reviews in Biotechnology 34:3, pages 258-268.
Read now
Thomas Ming Swi Chang. (2004) Artificial Cell Bioencapsulation in Macro, Micro, Nano, and Molecular Dimensions: Keynote Lecture. Artificial Cells, Blood Substitutes, and Biotechnology 32:1, pages 1-23.
Read now
Thomas Ming Swi Chang. (2003) Artificial Cells for Replacement of Metabolic Organ Functions. Artificial Cells, Blood Substitutes, and Biotechnology 31:2, pages 151-161.
Read now

Articles from other publishers (19)

Josemar Gonçalves de Oliveira Filho, Adriana Sousa e Silva Carvalho, Jordana dos Santos Alves & Mariana Buranelo Egea. (2022) Next-generation probiotics as a therapeutic strategy for the treatment of phenylketonuria: a review. Nutrition Reviews 80:10, pages 2100-2112.
Crossref
Fabio Parmeggiani, Nicholas J. Weise, Syed T. Ahmed & Nicholas J. Turner. (2017) Synthetic and Therapeutic Applications of Ammonia-lyases and Aminomutases. Chemical Reviews 118:1, pages 73-118.
Crossref
Katherine E. Durrer, Michael S. Allen & Ione Hunt von Herbing. (2017) Genetically engineered probiotic for the treatment of phenylketonuria (PKU); assessment of a novel treatment in vitro and in the PAHenu2 mouse model of PKU. PLOS ONE 12:5, pages e0176286.
Crossref
Luigia Rossi, Francesca Pierigè, Antonella Antonelli, Noemi Bigini, Claudia Gabucci, Enrico Peiretti & Mauro Magnani. (2016) Engineering erythrocytes for the modulation of drugs' and contrasting agents' pharmacokinetics and biodistribution. Advanced Drug Delivery Reviews 106, pages 73-87.
Crossref
Thomas Ming Swi Chang. 2013. Biomaterials Science. Biomaterials Science 811 827 .
Jaspreet Singh Kochhar, Sui Yung Chan, Pei Shi Ong & Lifeng Kang. (2012) Clinical therapeutics for phenylketonuria. Drug Delivery and Translational Research 2:4, pages 223-237.
Crossref
Yueling Zhang, Xingyuan Jia, Lianyan Wang, Jingzhong Liu & Guanghui Ma. (2011) Preparation of Ca-Alginate Microparticles and Its Application for Phenylketonuria Oral Therapy. Industrial & Engineering Chemistry Research 50:7, pages 4106-4112.
Crossref
. (2009) Biochemical Characterizations of Phenylalanine Ammonia-Lyase and its Mutants to Develop an Enzymatic Therapy for Phenylketonuria. Journal of Life Science 19:9, pages 1226-1231.
Crossref
Christineh N. SarkissianAlejandra Gámez, Lin Wang, Marilyse CharbonneauPaul Fitzpatrick, Jeffrey F. Lemontt, Bin Zhao, Michael Vellard, Sean M. Bell, Carroll Henschell, Amy Lambert, Laurie Tsuruda, Raymond C. Stevens & Charles R. Scriver. (2008) Preclinical evaluation of multiple species of PEGylated recombinant phenylalanine ammonia lyase for the treatment of phenylketonuria. Proceedings of the National Academy of Sciences 105:52, pages 20894-20899.
Crossref
M. Lam, C. H. Scaman, S. Clemens & A. Kermode. (2008) Retention of Phenylalanine Ammonia-lyase Activity in Wheat Seedlings during Storage and in Vitro Digestion. Journal of Agricultural and Food Chemistry 56:23, pages 11407-11412.
Crossref
Andrea Goldson, Melanie Lam, Christine H Scaman, Sabine Clemens & Allison Kermode. (2008) Screening of phenylalanine ammonia lyase in plant tissues, and retention of activity during dehydration. Journal of the Science of Food and Agriculture 88:4, pages 619-625.
Crossref
Alejandra Gámez, Lin Wang, Christineh N. Sarkissian, Dan Wendt, Paul Fitzpatrick, Jeffrey F. Lemontt, Charles R. Scriver & Raymond C. Stevens. (2007) Structure-based epitope and PEGylation sites mapping of phenylalanine ammonia-lyase for enzyme substitution treatment of phenylketonuria. Molecular Genetics and Metabolism 91:4, pages 325-334.
Crossref
T M S CHANG. 2007. Artificial Cells, Cell Engineering and Therapy. Artificial Cells, Cell Engineering and Therapy 321 332 .
John H. Walter, Philip J. Lee & Peter Burgard. 2006. Inborn Metabolic Diseases. Inborn Metabolic Diseases 221 232 .
Alejandra Gámez, Christineh N. Sarkissian, Lin Wang, Woomi Kim, Mary Straub, Marianne G. Patch, Lin Chen, Steve Striepeke, Paul Fitzpatrick, Jeffrey F. Lemontt, Charles O'Neill, Charles R. Scriver & Raymond C. Stevens. (2005) Development of Pegylated Forms of Recombinant Rhodosporidium toruloides Phenylalanine Ammonia-Lyase for the Treatment of Classical Phenylketonuria. Molecular Therapy 11:6, pages 986-989.
Crossref
Thomas Ming Swi Chang. (2005) Therapeutic applications of polymeric artificial cells. Nature Reviews Drug Discovery 4:3, pages 221-235.
Crossref
Thomas Ming Swi Chang. 2005. Applications of Cell Immobilisation Biotechnology. Applications of Cell Immobilisation Biotechnology 249 255 .
C.J Hendriksz & J.H Walter. (2004) Update on phenylketonuria. Current Paediatrics 14:5, pages 400-406.
Crossref
Thomas Ming Swi Chang. (2004) Artificial Cells for Cell and Organ Replacements. Artificial Organs 28:3, pages 265-270.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.